National Academies Press: OpenBook

Financing Vaccines in the 21st Century: Assuring Access and Availability (2004)

Chapter:Appendix B: List of Contributors

« Previous: Appendix A: Recommended Vaccine Schedules (Childhood and Adult)
Suggested Citation:"Appendix B: List of Contributors." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page235
Suggested Citation:"Appendix B: List of Contributors." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page236
Suggested Citation:"Appendix B: List of Contributors." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page237
Suggested Citation:"Appendix B: List of Contributors." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page238

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix B List of Contributors CENTERS FOR DISEASE CONTROL AND PREVENTION NATIONAL IMMUNIZATION PROGRAM Walter Orenstein, Director Lance Rodewald, Associate Director for Science Martin Landry, Associate Director, Planning, Evaluation and Legislation Bill Gallo, Associate Director, Policy Planning and Legislation Achal Bhatt, Program Officer Lawrence Barker, Assessment Branch Mary Ann Bryant, Contracting Officer Margaret Coleman, Economist K.C. Edwards, Program Officer Rex Ellington, Technical Project Officer Lisa Galloway, National Immunization Program Alison Johnson, Deputy Director, Immunization Services Division Laurie Johnson, Deputy Director, Epidemiology and Surveillance Division Sharon Katz, Acting Director, Office of Program Planning and Evaluation Glen Koops, Branch Chief, Program Operations Kimberly Lane, Deputy Associate Director, Management and Operations Robert Linkins, Chief, Systems Development Branch 235

236 FINANCING VACCINES IN THE 21ST CENTURY Dean Mason, Chief, Program Support Branch, Immunization Services Division Dennis O'Mara, Associate Director for Adult Immunization Abigail Shefer, Chief, Health Services Research and Evaluation Branch Philip Smith, National Immunization Program Michael Washington, Industrial Engineer, Data Management Division Bruce Weniger, Assistant Chief for Vaccine Development Melinda Wharton, Director, Epidemiology and Surveillance Division OTHER CONTRIBUTORS Mohammad Akhter, American Public Health Association Bud Anthony, Great Falls, VA Harris Berman, Tufts Health Plan Carmella Bocchino, American Association of Health Plans Damian Braga, Aventis Pasteur Kristin Butterfield, American Academy of Pediatrics Boyd Clarke, Neose Technologies Martha Cook, American Academy of Pediatrics Charles Cutler, American Association of Health Plans lean Davis, Director, American Academy of Pediatrics Henry Desmarais, Health Insurance Association of America Gordon Douglas, Princeton, Nr John DuMoulin, American College of Physicians-American Society of Internal Medicine Geoffrey Evans, Health Resources and Services Administration Thomas Fileccia, Department of Defense John Fontenesi, University of California at San Diego David Friend, Watson Wyatt Worldwide Lisa German-Foster, Office of Senator rack Reed Geno Germano, Wyeth-Lederle Barry Gershon, GlaxoSmithKline Jayne Gilbert, Chiron ruliana Gonen, Washington Business Group on Health John Grabenstein, U.S. Army Medical Command Henry Grabowski, Duke University Christine Grant, Aventis Pasteur Robert Gribble, Marshfield Clinic Claire Hannan, Association of State and Territorial Health Officials Maxine Hayes, Washington State Health Department Janet Heinrich, General Accounting Office Karen Hendricks, American Academy of Pediatrics Sarah Henning, Marshfield Clinic

APPENDIX B Bill Herman, Highsmith Inc. Susan Hildebrandt, American Association of Family Physicians Linda Hilson, IMS Health, UK Phil Hosbach, Aventis Pasteur William Howell, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD Noreen Hunt, Children's Primary Care Medical Group, San Diego Hejab Imteyaz, Washington, DC rake Jacobs, Capitol Outcomes Research Inc. Scott ranch, American College of Physicians-American Society of Internal Medicine Susan Lanza, Health Insurance Association of America r° Lecouliard, GlaxoSmithKline Greg Lehmann, National Business Coalition on Health Susan Lett, Massachusetts Department of Health Barbara Levine, Association of State and Territorial Health Officials Richard Levinson, American Public Health Association Clement Lewin, Chiron roan Mahanes, Centers for Medicare and Medicaid Services Adel Mahmoud, Merck Vaccine Division Henri Manasse, American Society of Health System Pharmacists Eugene Mascolo, Aventis Pasteur Mark Mathew, Parexel International Corporation Brian McKenna, Aventis Pasteur Patrick McLean, GlaxoSmithKline Suzanne Mercure, National Business Coalition on Health rack Meyer, Economic and Social Research Institute Allen Meyerhoff, Capitol Outcomes Research Inc. Kent Moore, American Association of Family Physicians Jessica Mullan, Office of Senator Richard Durbin Thomas Musco, Health Insurance Association of America Karen Nielsen, GlaxoSmithKline Jackie Noyes, American Academy of Pediatrics Ryan O'Connor, American Medical Group Association Peter Paradiso, Wyeth-Lederle Frank Pasquire, General Accounting Office rim Pawelski American Academy of Pediatrics Steve Pearlin, Geisinger Clinic Dean Perry, Geisinger Clinic Joe Piascentini, U.S. Department of Labor Chris Queram, Employer Healthcare Alliance Cooperative Sarah Radcliff, Pharmaceutical Research and Manufacturers Association Bob Rehm, American Association of Health Plans 237

238 FINANCING VACCINES IN THE 21ST CENTURY Janice Reichert, Tufts Center for the Study of Drug Development Robert Shoppe, Marshfield Clinic David Smith, Texas Tech University Natalie Smith, California Department of Health Services Rick Smith, Pharmaceutical Research and Manufacturers Association Dan Soland, GlaxoSmithKline Charles Stellar, American Association of Health Plans Litjen (L.r.) Tan, American Medical Association Eric Tischler, Aventis Pasteur Thomas Vernon, Merck Vaccine Division Dan Walter, American Academy of Pediatrics Piers Whitehead, VaxGen Patricia Willis, U.S. Department of Labor Lillian Woolett, Pharmaceutical Research and Manufacturers Association Elizabeth (Bitsy) York, GlaxoSmithKline Herbert Young, American Association of Family Physicians Barbara Zake, Geisinger Clinic Jennifer Zavolinsky, American Association of Health Plans Thomas Zink, GlaxoSmithKline

Next: Appendix C: Survey of State Vaccine Finace Practices »
Financing Vaccines in the 21st Century: Assuring Access and Availability Get This Book
×
Buy Paperback | $37.00 Buy Ebook | $29.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The national immunization system has achieved high levels of immunization, particularly for children. However, this system faces difficult challenges for the future. Significant disparities remain in assuring access to recommended vaccines across geographic and demographic populations. These disparities result, in part, from fragmented public–private financing in which a large number of children and adults face limited access to immunization services. Access for adults lags well behind that of children, and rates of immunizations for those who are especially vulnerable because of chronic health conditions such as diabetes or heart and lung disease, remain low.

Financing Vaccines in the 21st Century: Assuring Access and Availability addresses these challenges by proposing new strategies for assuring access to vaccines and sustaining the supply of current and future vaccines. The book recommends changes to the Advisory Committee on Immunization Practices (ACIP)-the entity that currently recommends vaccines-and calls for a series of public meetings, a post-implementation evaluation study, and development of a research agenda to facilitate implementation of the plan.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!